Dah Sing MedTech (02543) public offering received 7558.40 times oversubscriptions, netting around HK$342 million in global offering.

Da Hing Group (02543) announced the distribution results, with the company issuing 7.92 million H shares globally. The public offering in Hong Kong accounted for 10%, while the international offering accounted for 90%. The offering price per share was HK$49.5, resulting in a net fundraising of approximately HK$342 million. The shares are expected to begin trading on the Hong Kong Stock Exchange on Tuesday, September 9, 2025 at 9:00 am Hong Kong time. The public offering in Hong Kong was oversubscribed by 7,558.40 times, while the international offering was oversubscribed by 21.65 times.